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Abstract 
Two new diorganotin(IV) complexes, Me2SnL and Ph2SnL, have been synthesized from the 
reaction of Me2SnCl2 and Ph2SnCl2 with the hydrazone H2L [ H2L = (Furan-2-yl)(5-hydroxy-3-
methyl-5-phenyl-4,5-dihydro-1H-pyrazol-1-yl)-methanone ] derived from furan-2-
carbohydrazide and benzoylacetone. The new compounds have been characterized by elemental 
and spectroscopic analyses. The crystal structures of the monohydrate form of the ligand and of 
the Me2SnL derivative have been also determined by X-ray crystallography. Experimental 
evidences confirm the existence of the hydrazone ligand exclusively in cyclic form in both 
solution and solid state. On coordination to tin the hydrazone undergoes a ring opening reaction 
and a doubly deprotonation to act as a tridentate ligand via imine nitrogen and enolic oxygens. 
The tin atom in the complexes is five coordinate with geometry between square-pyramidal and 
trigonal-bipyramidal. The in vitro antibacterial activity of ligand and its complexes has been 
evaluated against Gram-positive (Bacillus subtilis and Staphylococcus aureus) and Gram-
negative (Escherichia coli and Pseudomonas aeruginosa) bacteria. The interaction between 
compounds with bacterial DNA was also studied by molecular docking. Our findings indicate 
that diphenyltin(IV) complex, by binding to DNA via minor groove to TATA sequence in genes 
upstream,  has good activities along with the standard antibacterial drugs. Our agarose-gel 
electrophoresis experiments show that the ligand exert DNA cleavage, while Me2SnL and 
Ph2SnL did not. 
 
Keywords: Organotin(IV), Hydrazone, Diketone, Antibacterial activity, DNA cleavage, 
Molecular docking 
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Introduction 
1,3-Diketones constitute an important class of compounds, which is used in organic chemistry 
for the synthesis of heterocycles [1, 2] and in coordination chemistry as ligand [3]. Moreover, 
Imines (Schiff bases) can be obtained from condensation of these dicarbonyl compounds and 
primary amines. The derived Schiff bases have keto-enol tautomerism with strong intramolecular 
hydrogen bonds (NH…O or N…HO). They are of biological interest, play as synthetic 
intermediates in organic reactions and act as sensor materials [4-6]. These compounds can also 
be used as coordination ligands for transition and non-transition metals; however, less attention 
has been paid to this type of systems. Recently we have reported synthesis, structural and 
theoretical studies and antibacterial activities of several Schiff bases derived from condensation 
of -diketones with aminophenol derivatives and their complexes with transition metals and 
organotins [7-12]. In continuation of our earlier work, we are herein reporting a hydrazonic 
derivative of a 1,3-diketone and its organotin(IV) complexes. Hydrazone-based Schiff base 
ligands, and their metal complexes have received much attention because of their potential 
pharmacological applications [13, 14]. Facile keto-enol tautomerization and the availability of 
several potential donor sites in these ligands allows and encourages chemists to construct 
complexes with large structural varieties [15]. Along this line, organotin(IV) complexes of 
hydrazones have received considerable attention for both structural and biological importance: 
many of these compounds may interact with biological systems in different ways as bactericides, 
fungicides, acaricides and industrial biocides [16-21]. Recently these compounds have been used 
in new contexts as in cancer chemotherapy [22, 23]. In view of a few reports on organotin(IV) 
complexes of hydrazones derived from 1,3-diketones [24-28], it was considered worthwhile to 
investigate the synthesis, structural aspects and biological properties of hydrazonic derivatives of 
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1,3-diketones and their organotin complexes. In the present paper, 2-furancarboxylic acid 
hydrazone derivative of benzoyl acetone and its dimethyl- and diphenyltin complexes have been 
synthesized. The solution and solid state structures as well as biological properties of ligand and 
complexes are reported. In order to elucidate the interaction mechanisms for these compounds, 
we performed In Silico experiments using molecular dynamic and docking. 
 
2. Experimental 
2.1. Materials and methods 
All starting materials were purchased from Merck while diphenyltin dichloride was supplied 
from Acros Company and were all used as received. All solvents were of reagent grade and used 
without further purification. IR spectra were obtained using a FT BOMEM MB102 
spectrophotometer. The 
1
H, 
13
C and 
119
Sn NMR spectra were recorded with Bruker Avance 
Ultrashield spectrometers using TMS and SnMe4 as references, respectively. 
 
2.2 Synthesis of the ligand (1) 
A solution of furan-2-carbohydrazide (0.630 g, 5 mmol) and benzoylacetone (0.81 g, 5 mmol) in 
ethanol (30 mL) was refluxed for 4 h. Cubic white single crystals were obtained after standing 
the solution for 3 days at room temperature (1a). Yield: 1.152 g (80 %), m.p. 128-132 
0
C; Anal. 
Calcd. For C 15H14N2O3: C, 62.49; H, 5.59; N, 9.71; Found: C, 62.22; H, 5.61; N, 9.83; FT-IR 
(KBr, cm
-1): ν(OH), 3396; ν(C=O), 1640; ν (C=N), 1626; ν(CH2), 1434; ν(C-O), 1318; ν(OH), 
1163; 
1
H NMR (250 MHz, CDCl3): δ = 2.16 (s, 3H, H9), 3.00 (d, 1H, H7, 
2
JHH =18.7 Hz), 3.34 
(d, 1H, H7, 
2
JHH = 18.7 Hz), 5.30 (s, 1H, OH), 6.57 (m, 1H, H2), 7.30 (d, 1H, H3, 
3
JHH = 4.0 Hz), 
7.32 - 7.46 (m, 4H, H1, 3ArH), 7.62 (m, 2H, 2ArH) (See Figure 3 for numbering). Synthesis of 1 
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in methanol gives the hydrated form of this compound as bright yellow crystals suitable for X-
ray crystallography (1b). 
 
2.3. Synthesis of Me2SnL (2) 
H2L (0.067 g, 0.25 mmol) was dissolved in ethanol (5 mL) and triethylamine (0.5 mmol) was 
added. This solution was stirred for 30 min and then SnMe2Cl2 (0.055 g, 0.25 mmol) in ethanol 
(5 mL) was added. The mixture was refluxed for 2 h. The yellow-orange crystals suitable for X-
ray crystallography were obtained after standing the solution for 2 days at room temperature. 
Yield: 0.337 g (81%); m.p. 147-150 

C; Anal. Calcd. For C17H18N2O3Sn: C, 48.95; H, 4.35; N, 
6.71 %. Found: C, 48.62; H, 4.78; N, 6.69;  FT-IR (KBr, cm
-1): ν(C=N), 1596; ν(C=N), 1586; 
νas(Sn-C),  597; ν(Sn-O), 551; νs(Sn-C),  522; ν(Sn-N), 456; 
1
H NMR (250 MHz, CDCl3): δ = 
0.83 [s, 6H, SnMe2, 
2
J(
117/119
Sn-
1
H) = 75.3/78.8 Hz]; 2.55 (s, 3H, H17); 5.66 (s, 1H, H7); 6.50 (m, 
1H, H1); 6.98 (dd, 1H, H3, 
3
JHH = 3.5, 
4
JHH = 0.75 Hz); 7.39-7.45 (m, 3H, H11,12,13); 7.54 (m, 1H, 
H2); 7.77-7.81  (m, 2H, H10,14); 
13
C NMR (62 MHz, CDCl3): δ = 1.38, C15,16; 23.75, C17; 94.43, 
C7; 111.48, C3; 111.97, C1; 126.59, C11,13; 128.30, C10,14; 130.35, C12; 138.68, C9; 143.98, C2; 
148.63, C4;157.92, C5; 170.05, C6; 174.00, C8.; 
119
SnNMR (111 MHz, CDCl3): δ = -149.5 (See 
Figure 5 for numbering). 
 
2.4. Synthesis of Ph2SnL (3) 
To solution of ligand (0.067 g, 0.25 mmol) in ethanol (5 ml), triethylamine (0.5 mmol) was 
added. This solution was stirred for 30 min and then Ph2SnCl2 (0.085 g, 0.25 mmol) in ethanol (5 
ml) was added. The reaction mixture was refluxed for 3h. A yellow precipitate was formed 
which was filtered, washed with ethanol and dried over CaCl2. Yield: 0.411 g (76%); m.p. 169-
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173 

C; Anal. Calcd. For C27H22N2O3Sn: C, 59.92; H, 4.09; N, 5.17 %. Found: C, 59.97; H, 4.42; 
N, 5.32; FT-IR (KBr, cm
-1): ν(C=N), 1596; ν(C=N), 1587; ν(Sn-O), 544; ν(Sn-N), 458; 1H NMR 
(250 MHz, CDCl3): δ = 2.57 (s, 3H, H17); 5.83 (s, 1H, H7); 6.57 (m, 1H, H1); 7.17 [(d, 1H, J = 
3.25 Hz, H3]; 7.40-7.46 [m, 6H. Hm,p(Ph2Sn)]; 7.52 (m, 3H, H11,12,13); 7.60 (m, 1H, H2); 7.85-
7.90 [m, 4H, Ho(Ph2Sn)]; 7.99-8.03 (m, 2H, H10,14); 
13
CNMR (CDCl3): δ = 23.90, C17; 95.22, C7; 
111.54, C3; 112.96, C1; 126.73, C11,13; 128.56, C10,14; 128.86, Cm [
3
J(
119
Sn
_13
C) = 85.6 Hz]; 
130.39, Cp [
2
J(
119
Sn
_13
C) = 17.3]; 130.67, C12; 136.10, Co [
2
J(
119
Sn
_13
C) = 54.3]; 138.24, C9; 
139.52, Ci; 144.31, C2; 148.58, C4; 156.35, C5; 170.15, C6; 174.05, C8; 
119
 Sn NMR (111 MHz, 
CDCl3): δ= -325.1(See Figure 5 for numbering). 
 
2.5. X-ray crystal structure determination 
X-ray data were collected on a Bruker Apex II diffractometer using MoK radiation. The 
structures were solved using direct methods and refined using a full-matrix least squares 
procedure based on F
2
 using all data [29]. Hydrogen atoms were placed at geometrically 
estimated positions. Details relating to the crystals and the structural refinements are presented in 
Table 1. Full details of crystal data and structure refinements, in CIF format, are available as 
Supplementary Materials. 
 
2.6. Antibacterial tests 
The in vitro antibacterial activity of ligand and its corresponding organotin(IV) complexes was 
studied against two Gram-positive (Bacillus subtilis ATCC 6633 and Staphylococcus aureus 
ATCC 6538) and two Gram-negative (Escherichia coli ATCC 25922 and Pseudomonas 
aeruginosa ATCC 9027) bacteria in Kirby-Bauer disc diffusion test according to the CLSI 
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standard protocols [30]. For this purpose, the test species were cultured in Muller-Hinton broth 
(Merck, Germany) and incubated at 37°C till 0.5 McFarland turbidity was obtained. A lawn 
culture was then prepared on Muller-Hinton agar (Merck, Germany) plates using sterile cotton 
swabs. The compounds were dissolved in CDCl3 at 10, 20, 40 and 80 mg/mL concentration and 
sterile blank discs (6.4 mm diameter) were saturated by these solutions. So, the final effective 
dose per disc was 0.4, 0.8, 1.6 and 3.2 mg. These discs were left for 15min at room temperature 
and then placed on lawn cultures. A blank disc saturated with CDCl3 was also prepared for each 
bacterial species and used as a control for solvent. The plates were incubated at 37 °C for 24 h. 
The inhibition zone diameters around each disk were measured in mm.  In order to compare the 
results, the effect of standard antibiotic discs including Vancomycin, Streptomycin, Penicillin, 
Nalidixic acid and Gentamicin were studied as previously mentioned.  
 
2.7. Gel electrophoresis assay 
The bacterial DNA was extracted by boiling method [31]. For this purpose, 1mL of bacterial 
suspension was centrifuged at 10000 rpm for 10 min. The precipitate was dissolved in 1 mL of 
sterile distilled water and boiled for 15 min at 100°C. A centrifuge at 5000 rpm for 1 min was 
then performed and the supernatant was harvested. Cold ethanol was added to this supernatant at 
2.5 V/V and remained overnight at -20°C. The DNA was precipitated by centrifugation at 13000 
rpm for 10min. Finally the precipitate was dissolved in 100 μL of DNase free sterile water. DNA 
was stored at -20°C till experiments. A 20 mg/mL solution of each compound in CHCl3 was 
prepared and 100 μL of this solution was mixed with 100 μL of DNA solution and incubated at 
37 °C for 2h. A positive control was prepared through mixing 100 μL of H2O2 with 100 μL of 
DNA and treated as same as previously described. Furthermore, an untreated DNA was regarded 
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as negative control. For finding if the DNA was affected by compounds, agarose gel 
electrophoresis was performed. One percent agarose was prepared in TAE buffer and boiled. 
DNA safe stain was added to the gel and poured in horizontal electrophoresis tray 0.5 μL  of 
each treated DNA was mixed with 2μL of loading dye and loaded in agarose gel. A 1Kb DNA 
ladder was also loaded in a well. Electrophoresis was done at 100 V for 50 min. The gel was 
documented under UV irradiation by UVI/TEC gel documentation.      
 
2.8. Molecular Dynamic and Docking experiment 
In order to study the expected interactions between H2L, Me2SnL and Ph2SnL with bacterial 
DNA, we constructed 24 base pair DNA in HyperChem software with three different zone of an 
AT rich region with 8 base pair that mimic TATA box, a GC rich region with 8 base pair that 
mimic GC region both found in upstream of promoter region of genes, and an intervening region 
composed of two successive AGTC box (8 base pair). This region mimics a regular portion of 
DNA in eukaryotic or prokaryotic cells. The DNA was placed in rectangular cubic box with 
dimensions of 3.7912.765.02 nanometers and filled with 7042 water molecule of TIP3P. The 
system was neutralized by adding equivalent number of sodium ions and the system energy was 
minimized to 300kJ/Mol at 37C and 1 atmosphere of pressure. The system was then 
equilibrated for a period of 10 nanosecond of simulation using Amber03 force filed. The 
equilibrated structure of DNA then transferred to Hex software installed in UBUNTU version 
14.04 and blind docking were performed and the best 200 solutions were extracted and analyzed 
in Excel and SPSS softwares. P-value under 0.05 was used as criteria of significance throughout 
our analysis. 
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3. Results and Discussion 
The acylhydrazone used in this work has been obtained from reaction of furan-2-carbohydrazide 
(2-furancarboxylic acid hydrazide) and benzoylacetone. Rateb et al. reported that the initial 
product of the condensation of benzoyl acetone and aroyl hydrazones is predominantly the 
enolimino form rather than the ketoenamine form and the former on cyclization gives a 5-
hydroxypyrazoline derivative which may exhibit ring-chain tautomerism in solution [32]. Figure 
1 show the synthesized acylhydrazone in cyclic and several chain tautomeric forms. Compound 1 
was obtained as anhydrous and hydrated and both forms were characterized by X-ray diffraction 
analyses. The new complexes 2 and 3 were prepared by reaction of R2SnCl2 [R = Me (2) and Ph 
(3)] with hydrazone ligand in ethanol in the presence of a base to force the deprotonation of the 
ligand. The new complexes were characterized by elemental analysis and IR, 
1
H, 
13
C and 
119
Sn 
NMR spectroscopy. The crystal structure of SnMe2L (2) has been also determined by X-ray 
diffraction. 
 
3.1. Spectroscopic studies 
The ligand exists exclusively in cyclic form in solid state as evidenced from comparison of its IR 
data with that of similar benzoylhydrazones [33] and as also confirmed from X-ray 
crystallography. In the IR spectrum of 1 a broad band observed at 3396 cm
-1
 has been assigned to 
OH stretching vibration. Two strong bands appearing at 1640 and 1626 cm-1 are attributed to 
amido carbonyl and azomethine stretching mode, respectively. The CH2 bending vibration is 
observed at 1434 cm
-1
, and CO stretching and OH bending modes correspond to bands at 1318 
and 1163 cm
-1
, respectively. In the IR spectra of organotin complexes the absence of any bands 
attributed to ν(O-H) or ν(N-H) shows complete deprotonation of hydrazone.  The lack of 
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absorption bands in the region 1725-1610 cm
-1
 excludes the possibility of a free or coordinated 
keto group in the chelated ligand. Two strong bands at 1596 and 1587 cm
-1
 in the IR spectra of 
both 2 and 3 have been assigned to the azometine stretching modes, ν(C=NN=C). This low 
frequency for ν(C=N) is expected on coordination of nitrogen and electron delocalization in the 
chelate ring. The appearance of new bands in the IR spectra of the synthesized complexes 
assigned to (Sn-N) and (Sn-O) supports the bonding of nitrogen and oxygen to the tin atom. 
The presence of both sym(Sn-C) and asym(Sn-C) in the IR spectrum of 2 is consistent with a 
nonlinear C-Sn-C configuration. The IR spectra of the two complexes are in accordance with the 
coordination of hydrazone as a dianionic tridentate ligand via imino nitrogen and enolic oxygens 
corresponding to enol tautomer of hydrazone (form I, Figure 1). 
The 
1
H NMR spectrum data of 1 in CDCl3 is presented in the experimental section 
according to the X-ray atomic numbering shown in Figure 3. This data denote that it exists 
exclusively in the cyclic form. The absence of any singlet signal corresponding to the methine, 
methylene, enol or amine protons indicate no participation of any chain tautomeric form in 
solution. A double doublet (
2
JHH = 18.7 Hz) at 3.00 and 3.34 ppm is attributed to two 
nonequivalent CH2 protons in cyclic form. The OH proton appears as a singlet at 5.30 ppm. 
The aromatic and furan ring protons are observed in the region 6.55-7.63 ppm.  
The 
1
H and 
13
CNMR data for 2 and 3 are presented in the experimental section according 
to the X-ray atomic numbering shown in Figure 5.
 
In the 
1
H NMR spectra of the two complexes, 
the absence of the signals corresponding to CH2 and hydroxyl protons, and the appearance of 
a singlet in the range 5.66-5.83 ppm (1H) assigned to the methine proton indicate that the ligand 
undergoes a ring opening with complete deprotonation and coordinate to tin as enol tautomeric 
form I (Figure 1). The 
1
H NMR spectrum of 2 shows a singlet for SnMe2 protons surrounded by 
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satellites with 
2
J(
117/119
Sn-
1
H) larger than for uncomplexed Me2SnCl2 (
2
J(
117/119
Sn-
1
H) = 65.7 / 
68.7 Hz ). Generally the larger coupling constant indicates the higher coordination number of tin 
[34]. Substitution of 
2
J(
119
Sn-
1
H) in the Lockhart-Manders equation [35], gives a value of 129.3
°
 
for Me-Sn-Me angle in chloroform solution.  
The 
119
SnNMR spectra of complexes in noncoordinating solvent (CDCl3) show one sharp 
singlet (-149.5 ppm for 1 and -325.1 ppm for 2) significantly at lower frequency than that of the 
original Me2SnCl2 (+137 ppm) and Ph2SnCl2 (-32 ppm) which is in agreement with the 
increasing of coordination number of tin [34]. On the basis of the chemical shifts observed 
empirically for phenyltin(IV) and methyltin(IV) complexes [7-10, 36-39], the coordination 
number of tin for both 2 and 3 is five in CDCl3.  
 
3.2. Crystal structures of 1 and 2 
Slow evaporation of ethanol or methanol solutions of compound 1 give single crystals of its 
anhydrous (1a) or monohydrate (1b) forms, respectively. The structure of the anhydrous 1a has 
been reported previously [40], while the monohydrate 1b structure is new. The crystal structure 
of 1b will be discussed here in detail while the structure of 1a will be only considered for 
comparison analysis. Relevant crystallographic information and selected bond distances and 
angles for 1b are reported in Tables 1 and 2, respectively. 
In both crystal structures (1a and 1b) the ligand molecule is present in its cyclic form as 
also observed in solution by 
1
H NMR spectroscopy. In the cyclic form the molecule is chiral for 
the presence of an asymmetric carbon atom and both anhydrous and monohydrate forms 
crystallize in the centrosymmetric monoclinic space group P21/c as racemic mixtures of R and S 
enantiomers. 
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The asymmetric unit of 1b contains one ligand molecule and one water molecule and its 
ORTEP representation with the atomic numbering is shown in Figure 3. The more relevant 
differences between the two crystal structures concern the hydrogen bonding involving the 
molecules. The anhydrous 1a show intermolecular hydrogen bonding between the hydroxyl 
group and carbonyl oxygen that led to the coupling of two adjacent molecules through a  (4) 
ring (Figure 2). This pattern shows the peculiar bifurcated hydrogen bond [41] with OH…O=C 
of 2.04 Å (intra-) and 2.47 Å  (intermolecular) observed in similar compounds [42, 43]. In 1b the 
presence of a water molecule breaks the dimers (and the bifurcated hydrogen bond) and the 
hydroxyl group is now involved in hydrogen bonding with the crystallization water molecule, 
carbonyl and hydroxyl groups of adjacent molecules. Therefore one water molecule (w) 
participates in three different hydrogen bonds that form chains with  (12) rings (Figure 4) with 
OH...O(w)  1.84 Å,  OH(w)...O=C 1.93 Å , OH(w)..O(H) 2.13 Å. 
The furan ring in 1a is disordered over two positions with CH/O occupancy of 44%-56%. 
This fact is supported by the absence of any hydrogen bonding involving the oxygen atom of the 
furan ring. Disorder is also present on the methyl group with occupancy of 18%-82% . The 
minor component has been removed from ORTEP shown in Figure 2. Contrary to 1a, there is no 
CH/O disorder of the furan ring in 1b that, however, still continue not to be involved in hydrogen 
bonding. A 50%-50% disorder on the CH3 group is present that has been removed from ORTEP 
shown in Figure 3.  Other significant differences between the crystal structures of 1a and 1b are 
not evident. Within the pyrazoline ring of 1b the double bond is located on the N(2)C(8) bond 
(1.2786(17) Å, see Table 2 to be compared with 1.2774(16) for 1a).  The dihedral angle between 
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the five membered rings is 4.74(8)° in 1b and  1.84(9)° in 1a. The deviations from planarity is 
0.002 Å (furan) and 0.033 Å (pyrazoline) in 1b and 0.003 Å  and 0.059 Å in 1a.   
Figure 5 shows an ORTEP view with the atomic numbering scheme for compound 
Me2SnL (2). Crystallographic information and selected bond distances and angles are given in 
Table 2 and 3 respectively. The X-ray structural investigation confirms a ring opening with a 
doubly deprotonation  of the ligand before to tridentately bind to tin(IV) metal atom through its 
ONO donor system. The tin atom is five coordinate and its coordination sphere is completed by 
two carbon atoms of methyl groups. The furan oxygen atom has no interaction with the tin 
center. To quantify the extent of distortion from ideal square pyramid (SP) or trigonal bipyramid 
(TBP), the index of trigonality, τ, defined by Reedijk and coworkers [44] have been used. The 
calculated τ value of 0.57 for 2 suggests a distorted geometry between square-pyramidal and 
trigonal-bipyramidal with the TBP predominating over the SP ( = 0.0 and 1.0 are for ideal SP 
and TBP geometries, respectively). This distortion is mainly due to the rigidity of the six and five 
membered chelate rings, and is supported by the large covalent radius of tin(IV). The two methyl 
groups and the azomethine N(2) atom of the ligand occupy the equatorial positions of the 
distorted TBP while the two oxygen atoms O(2) and O(3) coordinate at the axial positions. The 
rigidity of the ligand impose a decrease of the O(2)-Sn-O(3) angle from the ideal value of 180° 
to 157.57(7)°. The two chelate 5- and 6-rings are almost planar (max deviation from the average 
plane of 0.007 Å) and present a dihedral angle of 5.46(8)° .  In the chelate rings the distances 
C(5)-O(2), C(8)-O(3) and N(1)-N(2) approximate single-bond lengths whereas C(5)-N(1) and 
C(6)-N(2) are of order of a double bond (see Table 3) evidencing the occurrence of an electronic 
resonance and extensive delocalization. These observations give evidence that the ligand is 
coordinated according to the enol tautomeric form I (Figure 1).  
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The difference in the values for the C-Sn-C angle obtained from X-ray diffraction data, 
(120.83(15)

) and estimated in chloroform from NMR analysis (129.3
°
) may be related to 
removal of crystal network restriction in solution. The SnN and SnO bond lengths are close to 
the sum of the covalent radii of SnN (2.15 Å) and SnO (2.10 Å)  (see Table 3). As in the 
structure of 1a, the CH3 group and the furan ring of the ligand show disorder of 20%-80% and 
45%-55% occupancies, respectively. Only the major components have shown in Figure 5. 
 
3.3. Antibacterial studies 
The in vitro antibacterial activities of the Schiff bases and their organotin(IV) complexes were 
studied along with five standard antibacterial drugs, viz, Vancomycin, Streptomycin, penicillin, 
Nalidixic acid and Gentamycin. The microorganisms used in this work include Bacillus subtilis 
and Staphylococcus aureus (as Gram-positive bacteria) and Escherichia coli and Pseudomonas 
aeruginosa (as Gram-negative bacteria). The results are presented in Table 4. An inhibition zone 
diameter over 7 mm indicates that the ligand and its phenyltin complex are active against all 
bacteria under investigation [45]. Compound 1 exhibits moderate activity only in high 
concentration. In general the antibacterial activity of the Schiff bases may be attributed to OH 
and the imine group which interacts with active biological centers impairing normal cellular 
processes [46]. Complex 3 exhibit more inhibitory effects than the parent ligand, while almost no 
antibacterial effect was observed for complex 2. More inhibitory effects of 3 than the parent 
ligand may be due to electron delocalization over the whole chelate ring which increases the 
lipophilicity of molecule (chelation theory) [45, 47-49] and also because of the biological 
activity effects of diphenyltin moiety. The higher activity of diphenyltin than dimethyltin 
complex may also be attributed to the lipophilicity increased by the presence of two phenyl 
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groups [50]. Generally, biological activity of organotin complexes is influenced both by donor 
ligand and by the number and nature of the organic groups bound to tin. The mechanism is still 
unknown; however, since permeability across the bacterial cell wall is necessary for the 
effectiveness of the biocide compounds, therefore lipophilicity is an important factor that 
increasing the solubility of molecule in lipids facilitates microorganism membrane crossing. 
With regard to the data published earlier, within the diorganotin(IV) class, the highest activity is 
exerted by the [Et2Sn(IV)]
2+
 and [Ph2Sn(IV)]
2+
 complexes [51]. On the other hand, di-phenyl-
tin(IV) derivatives often are less toxic than other di-organo-tin(IV) derivatives [52-54]. It is 
interesting that 3 has remarkable activity towards P. aeruginosa while, the bacteria of the genus 
Pseudomonas are a group of resistant microorganism that many standard drugs were found to 
have no activity against it [55, 56]. 
 
3.4. DNA damage studies  
The synthesized compounds have been investigated for their DNA cleavage activity by agarose 
gel electrophoresis method. Figure 6 represents the electrophotogram for the cleavage activity of 
the 1–3 on the isolated DNA of B. subtilis and P. aeruginosa compared to the control DNA of 
bacteria. The results show that 2 and 3 have no significant effects on DNA structure due to the 
fact that the whole genomic DNA of B. subtilis and P. aeruginosa treated with these compounds 
formed a sharp band in agarose well. With regard to the results of antibacterial activity (Table 4), 
it can be concluded that 3 can inhibit bacterial growth and multiplication by affecting bacterial 
cell envelope or possibly interfering with metabolic pathways whereas, it is not harmful for DNA 
structure. The compound 1 in this experiment had considerable destructive effects on isolated 
DNA of P. aeruginosa, while it showed no apparent inhibitory effect against corresponding 
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bacteria (Table 4). It may be attributed to the low permeability of this compound across the 
bacterial cell wall. Furthermore, because of the presence of active groups in 1, this compound 
can react with active substituents present on the outer face of bacterium and deactivate them. 
Based on the results obtained from molecular dynamic and docking experiments (section 3.5), 
compound 1 can't affect gene expression in target bacteria and if it can reach DNA, will be able 
to bind with major groove of DNA and destruct it. While 2 and 3, through binding with minor 
groove and also attachment to the upstream of genes, can disturb gene expression and 
consequently interfere with metabolic pathways. So, as a consequent of metabolic disorders 
killing of target bacteria will happen. Further complementary studies are needed to examine this 
hypothesis that if 2 and 3 can be used for selective gene silencing in bacterial plasmids. The 
absence of destructive effect on bacterial DNA can be an advantage for Ph2SnL, hence this 
compound can be used safely for bacterial growth control in environment without any side 
effects on eukaryotic DNA. In other word, this compound will not be mutagen for eukaryotic 
cells. 
 
3.5. Molecular Docking experiments 
Our docking experiments indicate that the free ligand, unlike complexes, intercalates to DNA via 
its major groove and positions its hydroxy and keto groups toward N-glycosidic linkage of 
nucleotides and phosphordiester bonds. Because of the ligand potential to attack these bonds, the 
damage seen in our DNA cleavage experiments could be interpreted easily. Moreover our 
docking experiments also show that 2 and 3 bind strongly to DNA minor groove with 
hydrophobic (stacking) interactions. Analysis of 200 best solution of blind docking indicates that 
in 55% of solutions, compound 1 preferred to binds to regular part of DNA with binding energy 
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of -179.44  10.02 kJ / Mol (MeanSD), while in 12% and 33% of solutions compound 1 binds 
to AT and GC rich sequences of DNA respectively. This finding means that compound 1 has no 
effect on gene expression with any biological effects on normal or abnormal either in eukaryotic 
or prokaryotic cells. Our data also show that 2 and 3 preferred to bind to AT rich region from 
minor groove side with 68% and 72% respectively. It is well known that AT rich or TATA box 
(also called Goldberg-Hogness box) is a DNA sequence found in the promoter region of genes 
and molecules with biological effects may act with this element [57]. Binding energy for 2 and 3 
to DNA string is calculated as -211.02  12.5 and -236.74  15.03 kJ / Mol respectively. 
Considering higher binding energy (p-value < 0.001) for 3 in contrast 2, the more antibacterial 
effect of 3 could be easily understood. 
 
4. Conclusion 
Two new diorganotin(IV) complexes have been synthesized from reaction of diorganotin(IV) 
dichloride with a hydrazonic Schiff base derived from 2-furancarboxylic acid hydrazone and 
benzoyl acetone. On the basis of spectral and structural investigations, the Schiff base exists as 
cyclic form in both solution and solid phase. A novel monohydrate form of the ligand has been 
also obtained and structurally characterized. The ligand undergoes a ring opening reaction on 
complexation and coordinates to tin as tridentate dianion via imine nitrogen and enolic oxygens. 
The geometry of complexes is between square-pyramidal and trigonal-bipyramidal and on the 
basis of 
119
Sn NMR data, coordination number of tin retains five in solution. Complex 3, through 
binding with minor groove of DNA, exhibited good inhibitory effect and in view of less toxicity 
of diphenyltin(IV) derivatives, 3 may be a good candidate for anticancer studies. On the other 
18 
 
hand, due to absence of destructive effect for 3 on bacterial DNA, it can be also used safety in 
environment.  
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Figure 1. Tautomeric forms for 1 
Figure 2. An ORTEP view with a representation of intra- and intermolecular hydrogen bonds 
and formation of (4) ring in 1a 
Figure 3. An ORTEP view with the atomic numbering scheme for 1b 
Figure 4. A representation of intermolecular hydrogen bonds and formation of a  (12) ring in 
1b. 
Figure 5. An ORTEP view with the atomic numbering scheme for 2 
Figure 6. The electrophotogram for the DNA cleavage activity of the 1–3. M = DNA ladder 
(1kb), 1 = 2 + B. subtilis DNA, 2 = 2 + P. aeruginosa DNA, 3 = 1 + B. subtilis DNA , 4 = 1 + P. 
aeruginosa DNA, 5 = 3 + B. subtilis DNA , 6 = 3 + P. aeruginosa DNA, 7 = B. subtilis DNA + 
H2O2, 8 = P. aeruginosa DNA + H2O2, 9 = unreacted DNA of B. subtilis, 10 =  unreacted DNA 
of P. aeruginosa 
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Figure 6. The electrophotogram for the DNA cleavage activity of the 1–3. M = DNA ladder 
(1kb), 1 = 2 + B. subtilis DNA, 2 = 2 + P. aeruginosa DNA, 3 = 1 + B. subtilis DNA , 4 = 1 + P. 
aeruginosa DNA, 5 = 3 + B. subtilis DNA , 6 = 3 + P. aeruginosa DNA, 7 = B. subtilis DNA + 
H2O2, 8 = P. aeruginosa DNA + H2O2, 9 = unreacted DNA of B. subtilis, 10 =  unreacted DNA 
of P. aeruginosa 
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Table 1 Crystallographic and structure refinement data for 1b and 2 
 
 1b 2 
Empirical formula C15H16N2O4 C17H18N2O3Sn 
Formula weight 288.30 417.02 
T (K) 293(2) 293(2) 
Wavelength, λ (Å) 0.71073 A   0.71073 A 
Crystal system Monoclinic Monoclinic 
Space group P 21/c P 21/c 
a (Å)      12.6310(15) 11.767(7) 
b (Å) 6.8000(8) 7.823(5) 
c (Å) 17.143(2) 19.180(12) 
 (˚) 90.00 90.00 
β (˚) 105.063(2) 100.084(8) 
γ (˚) 90.00 90.00 
Volume (Å
3
) 1421.8(3) 1738.3(19) 
Z 4 4 
Dcalc. (Mg m
-3
) 1.347 1.593 
θ Ranges for data collection (˚)  1.670 to 31.605 1.758 to 31.564 
F(000) 608 832 
Crystal size (mm) 0.20 x 0.30 x 0.34 0.40 x 0.40 x 0.24 
Absorption coefficient (mm
-1
) 0.099 1.485 
Index ranges -18<=h<=18 -17<=h<=17 
  -10<=k<=10 -11<=k<=11 
 -25<=l<=25 -27<=l<=28 
Reflections collected / unique 30465 / 4472 38642 / 5525 
 [R(int) = 0.0223] [R(int) = 0.0197] 
Data / restraints / parameters     4472 / 0 / 198 5525 / 0 / 210 
Goodness-of-fit on F
2
 1.098 1.177 
Final R indices [I>2(I)] R1 = 0.0494 R1 = 0.0280 
 wR2 = 0.1390 wR2 = 0.0773 
R indices (all data) R1 = 0.0604 R1 = 0.0327 
 wR2 = 0.1537 wR2 = 0.0891 
Largest diff. peak and hole (e.A
-3
) 0.414 and -0.336 0.751 and -0.889 
Table(s)
Table 2. Selected bond lengths (Å), bond angles () and torsion angles () for 1b 
C(6)N(1) 1.5050(15) 
C(6)O(2) 1.3923(15) 
C(6)C(7) 1.5475(17) 
C(6)C(10) 1.5216(16) 
N(1)N(2) 1.3926(14) 
N(1)C(5) 1.3562(16) 
O(3)C(5) 1.2327(15) 
N(2)C(8) 1.2786(17) 
C(5)C(4) 1.4740(17) 
C(7)C(8) 1.4906(19) 
C(8)C(9) 1.491(2) 
  
N(1)- C(6)- O(2) 111.59(9) 
N(1)- C(6)- C(7) 99.77(9) 
C(6)- N(1)- N(2) 113.37(9) 
N(2)- N(1)- C(5) 122.89(10) 
N(1)- N(2)- C(8) 108.03(10) 
N(1)- C(5)- O(3) 119.9(1) 
N(1)- C(5)- C(4) 119.21(10) 
C(6)- C(7)- C(8) 103.83(10) 
N(2)- C(8)- C(7) 114.78(11) 
N(2)- C(8)- C(9) 121.22(13) 
  
C(7)-C(6)-N(1)-N(2) -4.31(12) 
N(1)-C(6)-C(7)-C(8) 4.35(11) 
C(6)-N(1)-N(2)-C(8) 2.35(14) 
N(1)-N(2)-C(8)-C(7) 0.98(15) 
C(6)-C(7)-C(8)-N(2) -3.68(15) 
  
O(1)W-H(1)W .. O(3) 2.7758(15) 
O(1)W-H(2)W .. O(2) 2.8713(15) 
O(2)-H(21) .. O(1)W 2.6597(15) 
 
Table(s)
Table 3. Selected bond lengths (Å), bond angles () and torsion angles () for 2 
Sn(1)-N(2) 2.156(2) N(2)-N(1) 1.405(2) 
Sn(1)-O(2) 2.1352(19) C(6)-C(7) 1.424(3) 
Sn(1)-O(3) 2.107(2) N(1)-C(5) 1.306(3) 
Sn(1)-C(15) 2.123(3) C(8)-C(7) 1.380(3) 
Sn(1)-C(16) 2.124(3) C(8)-O(3) 1.304(3) 
N(2)-C(6) 1.326(3) O(2)-C(5) 1.311(3) 
    
N(2)-Sn(1)-O(2) 74.40(7) C(6)- N(2)- N(1) 115.70(17) 
N(2)-Sn(1)-O(3) 84.67(7) Sn(1)-O(2)-C(5) 112.81(13) 
N(2)-Sn(1)-C(15) 115.72(12) Sn(1)-O(3)-C(8) 130.13(15) 
N(2)-Sn(1)-C(16) 123.29(2) N(2)-C(6)-C(7) 123.13(19) 
O(2)-Sn(1)-O(3) 157.57(7) C(17)-C(6)-N(2) 119.22(18) 
O(2)-Sn(1)-C(15) 97.79(11) N(2)-N(1)-C(5) 111.25(18) 
O(2)-Sn(1)-C(16) 93.72(11) N(1)-C(5)-O(2) 125.83(19) 
O(3)-Sn(1)-C(15) 98.51(12) N(1)-C(5)-C(4) 117.7(2) 
O(3)-Sn(1)-C(16) 91.06(12) C(9)-C(8)-O(3) 114.56(18) 
C(15)-Sn(1)-C(16) 120.83(15) C(7)-C(8)-O(3) 124.72(19) 
Sn(1)-N(2)-C(6) 128.57(14) C(6)-C(7)-C(8) 127.63(19) 
Sn(1)-N(2)-N(1) 115.70(13)   
    
N(2)-N(1)-C(5)-O(2) 1.3(6) N(2)-Sn(1)-O(3)-C(8) 11.2(2) 
O(2)-Sn(1)-N(2)-N(1) 0.8(1) Sn(1)-N(2)-C(6)-C(7) 5.1(3) 
O(3)-Sn(1)-N(2)-C(6) -9.5(2) Sn(1)-N(2)-N(1)-C(5) -1.2(2) 
N(2)-C(6)-C(7)-C(8) 3.1(6) C(7)-C(8)-O(3)-Sn(1) -8.3(3) 
O(3)-C(8)-C(7)-C(6) -1.7(4) Sn(1)-O(2)-C(5)-N(1) -0.3(3) 
N(2)-Sn(1)-O(2)-C(5) -0.3(1)   
 
Table(s)
 Table 4 Antibacterial activity data of ligand and its organotin(IV) complexes 
Compound 
Conc. 
(mg/disc) 
Inhibition zone (mm) 
E. Coli P. aeruginosa S. aureus B. subtilis 
H2L  (1) 3.2 
1.6 
0.8 
0.4 
11 
10 
9 
n.a. 
10 
9 
8 
7 
11 
10 
9 
7 
12 
10 
9 
n.a. 
SnMe2L (2) 3.2 
1.6 
0.8 
0.4 
12 
n.a. 
n.a. 
n.a. 
12 
n.a. 
n.a. 
n.a. 
n.a. 
n.a. 
n.a. 
n.a. 
n.a. 
n.a. 
n.a. 
n.a. 
SnPh2L
  
(3) 3.2 
1.6 
0.8 
0.4 
12 
11 
10 
n.a. 
22 
20 
15 
13 
17 
14 
12 
11 
21 
17 
15 
13 
Vancomycin 30 14 n.a. 17 24 
Streptomycin 10 16 n.a. 12 22 
Penicilin 10 12 n.a. 26 13 
Nalidixic acid 30 25 n.a. 12 23 
Gentamicin 10 20 20 16 21 
n.a. = no activity 
 
Table(s)
